Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

BACKGROUND: To determine whether initiation of a tumor necrosis factor inhibitor (TNFi) or methotrexate improves hemoglobin A1c in patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), or ankylosing spondylitis (AS) who also have diabetes mellitus (DM). METHODS: A retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantravadi, Santhi, George, Michael, Brensinger, Colleen, Du, Min, Baker, Joshua F., Ogdie, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466800/
https://www.ncbi.nlm.nih.gov/pubmed/32905192
http://dx.doi.org/10.1186/s41927-020-00138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466800/
https://www.ncbi.nlm.nih.gov/pubmed/32905192
http://dx.doi.org/10.1186/s41927-020-00138-3

Ejemplares similares